← Leaderboards
Nigel Mackman
Univ Of North Carolina Chapel Hill
$23,794,157
Attributed
$30,630,743
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,630,743 · 15
By mechanism
R01$14,541,964 · 8
U01$7,568,452 · 1
R35$4,577,076 · 1
P01$3,933,251 · 3
R13$10,000 · 1
M01$0 · 1
Top collaborators
- Nigel S Key11 shared
- Rafal L Pawlinski5 shared
- Kenneth I Ataga4 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Seth A Berkowitz$9,978,614
- Rafal L Pawlinski$8,739,544
- Nigel S Key$14,906,926
- Yun Li$11,441,630
- Michelle Meyer$10,396,429
Others in their field
Top investigators on “Thromboplastin”
- Bruce Furie · Beth Israel Deaconess Medical Center$17,405,630
- Steven Kyle Grinspoon · Massachusetts General Hospital$15,733,410
- Pamela Susan Douglas · Duke University$15,733,410
- Wolfram Ruf · Scripps Research Institute$11,941,457
- James H. Morrissey · University Of Oklahoma Hlth Sciences Ctr$11,467,893
- John T McDevitt · University Of Maryland Baltimore$10,396,534
Research focus
ThromboplastinThrombinCoagulation ProcessPathway InteractionsPeptide HydrolasesLeadThrombosisBlood CoagulationMouse ModelEndothelial CellsCellsCell TypeMonocyteComplexLaboratory MouseInflammationInhibitor/AntagonistMacrophageBlood PlateletsGene ExpressionGenerationsProgramsMediatingPathogen
Grant awards (65)
Tissue factor-dependent coagulation in thrombosis and immune responses$933,000
R35 · FY2025 · HL · contact PI
Tissue factor-dependent coagulation in thrombosis and immune responses$914,340
R35 · FY2024 · HL · contact PI
Tissue factor-dependent coagulation in thrombosis and immune responses$933,000
R35 · FY2023 · HL · contact PI
Tissue factor-dependent coagulation in thrombosis and immune responses$933,000
R35 · FY2022 · HL · contact PI
Tissue factor-dependent coagulation in thrombosis and immune responses$863,736
R35 · FY2021 · HL · contact PI
mechanism of venous thrombosis in pancreatic cancer$554,371
R01 · FY2020 · HL · contact PI
Role of the Thrombin PAR-1 Pathway in Viral Infection$388,750
R01 · FY2020 · HL · contact PI
mechanism of venous thrombosis in pancreatic cancer$554,371
R01 · FY2019 · HL · contact PI
Role of the Thrombin PAR-1 Pathway in Viral Infection$388,750
R01 · FY2019 · HL · contact PI
Role of the Thrombin PAR-1 Pathway in Viral Infection$388,750
R01 · FY2018 · HL · contact PI
Targeted Anticoagulant Therapy for Sickle Cell Disease$1,481,743
U01 · FY2017 · HL
Role of the Thrombin PAR-1 Pathway in Viral Infection$388,750
R01 · FY2017 · HL · contact PI
Targeted Anticoagulant Therapy for Sickle Cell Disease$1,481,743
U01 · FY2016 · HL
Role of the Thrombin PAR-1 Pathway in Viral Infection$380,000
R01 · FY2016 · HL · contact PI
Targeted Anticoagulant Therapy for Sickle Cell Disease$1,459,516
U01 · FY2015 · HL
Role of the Thrombin PAR-1 Pathway in Viral Infection$374,300
R01 · FY2015 · HL · contact PI
Targeted Anticoagulant Therapy for Sickle Cell Disease$1,452,109
U01 · FY2014 · HL
Role of the Thrombin PAR-1 Pathway in Viral Infection$372,400
R01 · FY2014 · HL · contact PI
Targeted Anticoagulant Therapy for Sickle Cell Disease$1,693,341
U01 · FY2013 · HL
Role of the Thrombin PAR-1 Pathway in Viral Infection$361,760
R01 · FY2013 · HL · contact PI
ROLE OF TISSUE FACTOR IN HEMOSTASIS & THROMBOSIS$291,696
P01 · FY2013 · HL · contact PI
Mechanisms of Venous Thromboembolism in Cancer$546,028
R01 · FY2012 · HL · contact PI
ROLE OF TISSUE FACTOR IN HEMOSTASIS & THROMBOSIS$306,403
P01 · FY2012 · HL · contact PI
Mechanisms of Venous Thromboembolism in Cancer$35,855
R01 · FY2012 · HL · contact PI
Mechanisms of Venous Thromboembolism in Cancer$488,797
R01 · FY2011 · HL · contact PI
ROLE OF TISSUE FACTOR IN HEMOSTASIS & THROMBOSIS$306,403
P01 · FY2011 · HL · contact PI
Mechanisms of Venous Thromboembolism in Cancer$493,735
R01 · FY2010 · HL · contact PI
Role of PAR-1 and PAR-2 in Cardiac Remodeling$371,119
R01 · FY2010 · HL · contact PI
ROLE OF TISSUE FACTOR IN HEMOSTASIS & THROMBOSIS$306,403
P01 · FY2010 · HL · contact PI
2010 Hemostasis Gordon Research Conference and/or Gordon Research Seminar$10,000
R13 · FY2010 · HL · contact PI
Mechanisms of Venous Thromboembolism in Cancer$505,706
R01 · FY2009 · HL · contact PI
Role of PAR-1 and PAR-2 in Cardiac Remodeling$370,941
R01 · FY2009 · HL · contact PI
Regulation of Inducible Gene Expression in Monocytes$365,000
R01 · FY2009 · HL · contact PI
ROLE OF TISSUE FACTOR IN HEMOSTASIS & THROMBOSIS$306,403
P01 · FY2009 · HL · contact PI
Mechanisms of Venous Thromboembolism in Cancer$497,330
R01 · FY2008 · HL · contact PI
Role of Tissue Factor in Atherosclerosis$450,079
P01 · FY2008 · HL · contact PI
Role of PAR-1 and PAR-2 in Cardiac Remodeling$370,768
R01 · FY2008 · HL · contact PI
Regulation of Inducible Gene Expression in Monocytes$365,000
R01 · FY2008 · HL · contact PI
Role of Tissue Factor in Atherosclerosis$462,054
P01 · FY2007 · HL · contact PI
Role of PAR-1 and PAR-2 in Cardiac Remodeling$382,100
R01 · FY2007 · HL · contact PI
Regulation of Inducible Gene Expression in Monocytes$365,000
R01 · FY2007 · HL · contact PI
Regulation of Inducible Gene Expression in Monocytes$1
R01 · FY2007 · HL · contact PI
Role of Tissue Factor in Atherosclerosis$408,058
P01 · FY2006 · HL · contact PI
Role of Tissue Factor in Atherosclerosis$396,173
P01 · FY2005 · HL
Thrombin-PAR-1 Signaling in Cardiac I/R Injury$377,800
R01 · FY2005 · HL
Regulation of inducible gene expression in monocytes$370,400
R01 · FY2005 · HL
Role of Tissue Factor in Atherosclerosis$384,633
P01 · FY2004 · HL
Thrombin-PAR-1 Signaling in Cardiac I/R Injury$377,800
R01 · FY2004 · HL
Regulation of inducible gene expression in monocytes$370,400
R01 · FY2004 · HL
BLOOD COAGULATION &FIBRINOLYSIS$354,600
R01 · FY2004 · HL
Thrombin-PAR-1 Signaling in Cardiac I/R Injury$377,800
R01 · FY2003 · HL
Regulation of inducible gene expression in monocytes$370,400
R01 · FY2003 · HL
BLOOD COAGULATION &FIBRINOLYSIS$357,234
R01 · FY2003 · HL
Thrombin-PAR-1 Signaling in Cardiac I/R Injury$399,100
R01 · FY2002 · HL
BLOOD COAGULATION &FIBRINOLYSIS$370,400
R01 · FY2002 · HL
Regulation of inducible gene expression in monocytes$370,400
R01 · FY2002 · HL
ROLE OF TISSUE FACTOR IN ANGIOGENESIS$0
P01 · FY2002 · HL
REGULATION OF INDUCIBLE GENE EXPRESSION IN MONOCYTES$0
M01 · FY2002 · RR
BLOOD COAGULATION &FIBRINOLYSIS$367,766
R01 · FY2001 · HL
INHIBITION OF GENE EXPRESSION IN ENDOTHELIAL CELLS$130,823
R01 · FY2001 · HL
ROLE OF TISSUE FACTOR IN ANGIOGENESIS$0
P01 · FY2001 · HL
BLOOD COAGULATION &FIBRINOLYSIS$354,600
R01 · FY2000 · HL
ROLE OF TISSUE FACTOR IN ANGIOGENESIS$314,946
P01 · FY2000 · HL
REGULATION OF INDUCIBLE GENE EXPRESSION IN MONOCYTES$282,859
R01 · FY2000 · HL
REGULATION OF INDUCIBLE GENE EXPRESSION IN MONOCYTES$0
M01 · FY2000 · RR